Novavax Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (52)

Latest Posts

About This Stock More About This Stock
Astrazeneca Vs. Novavax: Which Vaccine Stock Is A Better Buy?
Article By: StockNews
Saturday, February 13, 2021 7:41 PM EST
While neither Astrazeneca or Novavax will have a first-mover advantage if and when their vaccines are eventually brought to market their late-stage clinical trial results of AZN and NVAX are said to show a lot of promise.
In this article: AZN, NVAX
Read
My Biotech Investing Advice For 2021
Article By: Marc Lichtenfeld
Tuesday, January 19, 2021 5:05 AM EST
The J.P. Morgan Healthcare Conference is the most important healthcare investment conference of the year.
In this article: FOLD, NVAX, REGN, TGTX Also: JPM
Read
Johnson & Johnson Begins Two-Dose Phase 3 Trial Of COVID-19 Vaccine
Article By: Benzinga
Monday, November 16, 2020 6:22 AM EST
Johnson & Johnson has started the two-dose Phase 3 trial of its experimental COVID-19 vaccine, dubbed "ENSEMBLE 2," the pharmaceutical company announced Sunday.
In this article: AZN, JNJ, NVAX
Read
Healthcare Portfolio Performance - Small Stocks Perk Up!
Article By: Rod Raynovich
Saturday, November 14, 2020 2:43 PM EST
Three weeks ago, we suggested that investors stay the course with healthcare and biotech because of potential volatility with the 2020 Election and COVID-19 cases spiking. We have seen a big shift toward energy, financial, and industrial stocks.
In this article: ABBV, ABT, MRK, NVAX, PACB, MRNA, NTLA, OCUL, BHVN, TWST, BNTX, CVAC Also: DNLI, IWM, XBI
Read
How To Trade Pfizer Stock For A 290% Profit In A Month
Article By: Money Morning
Wednesday, November 11, 2020 10:42 AM EST
Today, though, I'm going to show you how you could almost quadruple your money on this stock – and you can do it for less than the cost of a big steak dinner.
In this article: PFE, NVAX Also: AZN, JNJ, MRNA, BNTX
Read

Latest Tweets for $NVAX

No tweets yet!

$NVAX

Astrazeneca Vs. Novavax: Which Vaccine Stock Is A Better Buy?
Alpha Stockman 2/15/2021 2:04:47 AM

The article isn’t wrong based off currently commercialized products (we have none)... and there is a chance that things could still end badly for $NVAX. But the odds are so much in our favor now that, at least for the next few weeks, investing in NVAX is like printing free money.

Astrazeneca Vs. Novavax: Which Vaccine Stock Is A Better Buy?
Adam Reynolds 2/14/2021 4:31:49 AM

This article states the #Novavax $NVAX is overvalued. Market cap? Revenue potential?

Novavax Analyst Says COVID-19 Vaccine Could Net $400M In Yearly Sales
Barry Hochhauser 7/1/2020 11:58:02 PM

Analyst can actually think a #Covid19 vaccine will only cost $.40 each since $NVAX has stated that they expect to produce 1 billlion doses in 2021, does he?

1 to 3 of 3 comments